ES520089A0 - Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina. - Google Patents

Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina.

Info

Publication number
ES520089A0
ES520089A0 ES520089A ES520089A ES520089A0 ES 520089 A0 ES520089 A0 ES 520089A0 ES 520089 A ES520089 A ES 520089A ES 520089 A ES520089 A ES 520089A ES 520089 A0 ES520089 A0 ES 520089A0
Authority
ES
Spain
Prior art keywords
arilic
piperacine
derivatives
procedure
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES520089A
Other languages
English (en)
Other versions
ES8403881A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES520089A0 publication Critical patent/ES520089A0/es
Publication of ES8403881A1 publication Critical patent/ES8403881A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES520089A 1982-02-26 1983-02-25 Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina. Expired ES8403881A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203256A FR2522325B1 (fr) 1982-02-26 1982-02-26 Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES520089A0 true ES520089A0 (es) 1984-04-16
ES8403881A1 ES8403881A1 (es) 1984-04-16

Family

ID=9271396

Family Applications (2)

Application Number Title Priority Date Filing Date
ES520089A Expired ES8403881A1 (es) 1982-02-26 1983-02-25 Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina.
ES529265A Granted ES529265A0 (es) 1982-02-26 1984-01-30 Procedimiento para la fabricacion de derivados de la piperacina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES529265A Granted ES529265A0 (es) 1982-02-26 1984-01-30 Procedimiento para la fabricacion de derivados de la piperacina

Country Status (16)

Country Link
US (1) US4639452A (es)
JP (1) JPS58159484A (es)
AU (1) AU1188983A (es)
BE (1) BE896009A (es)
CA (1) CA1246076A (es)
CH (1) CH657615A5 (es)
DE (1) DE3306302A1 (es)
ES (2) ES8403881A1 (es)
FR (1) FR2522325B1 (es)
GB (4) GB2116967B (es)
GR (1) GR77936B (es)
IT (1) IT1193684B (es)
LU (1) LU84658A1 (es)
NL (1) NL8300720A (es)
SE (1) SE460788B (es)
ZA (1) ZA831134B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
GB8530602D0 (en) * 1985-12-12 1986-01-22 Fujisawa Pharmaceutical Co Heterocyclic compounds
ATE60328T1 (de) * 1986-03-29 1991-02-15 Suntory Ltd Derivate vom benzoquinonylphenylalkansaeure-amid.
MY102447A (en) * 1986-06-16 1992-06-30 Ciba Geigy Ag Disubtituted piperazines
US5232923A (en) * 1988-03-18 1993-08-03 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives and pharmaceutical preparations containing same
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US6677343B2 (en) * 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
JPWO2004046110A1 (ja) * 2002-11-15 2006-03-16 アステラス製薬株式会社 メラニン凝集ホルモン受容体拮抗剤
KR20050114641A (ko) * 2003-03-07 2005-12-06 아스텔라스세이야쿠 가부시키가이샤 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체
JP5025266B2 (ja) * 2004-09-01 2012-09-12 アステラス製薬株式会社 ピペリジン誘導体又はその製薬学的に許容される塩
EP2220055A2 (en) * 2007-07-19 2010-08-25 F. Hoffmann-La Roche AG Novel heterocyclyl compounds and their use as chemokine antagonists
CN101591310B (zh) * 2008-12-19 2012-03-21 王绍杰 一种马来酸桂哌齐特的制备方法
US8673920B2 (en) 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CN101906085B (zh) * 2009-06-04 2013-12-11 天津药物研究院 治疗心脑血管疾病的化合物、组合物、制备方法及用途
CN101921247B (zh) * 2009-06-12 2016-04-20 福州璐珈医药科技有限公司 1-(肉桂酰基)-4-哌啶基酰胺哌嗪化合物及其制备方法
US9073882B2 (en) 2010-10-27 2015-07-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058134A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CN103874493A (zh) 2011-08-19 2014-06-18 默沙东公司 肾外髓质钾通道的抑制剂
US9527830B2 (en) 2011-09-16 2016-12-27 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US8999990B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771004B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773199B1 (en) 2011-10-31 2019-04-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9108947B2 (en) 2011-10-31 2015-08-18 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
WO2013066718A2 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013090271A1 (en) 2011-12-16 2013-06-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
EP2925322B1 (en) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2934533B1 (en) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9604998B2 (en) 2013-02-18 2017-03-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014150132A1 (en) 2013-03-15 2014-09-25 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139934A (en) * 1966-08-18 1969-01-15 Delalande Sa Cinnamylpiperazine preparations
GB1168108A (en) * 1967-09-29 1969-10-22 Delalande Sa Amide Derivatives of 1-Piperazine Acetic Acid and Process for their Preparation
GB1218591A (en) * 1968-04-03 1971-01-06 Delalande Sa Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation
FR2068407A6 (es) * 1969-10-17 1971-08-27 Delalande Sa
US3753984A (en) * 1971-05-26 1973-08-21 Delalande Sa Amides derived from the esters of 1-piperazine propionic acid, their method of preparation and their application to therapeutics
FR2262521A1 (en) * 1973-08-08 1975-09-26 Delalande Sa 3-(3,4,5-Trimethoxyphenyl)piperazines - with coronary vasodilator, hypotensive, antiinflammatory, analgesic, and antiulcer activity
FR2244518A1 (en) * 1973-08-10 1975-04-18 Delalande Sa N-sinapyl-N'-alkoxyalkyl or-aminocarbonylmethyl-piperazines - as vasodilators, diuretics, antihypertensive and antiulcer agents
FR2240734A1 (en) * 1973-08-13 1975-03-14 Delalande Sa N-(dihydro sinapyl) piperazine derivs - having antiulcer, hypertensive and diuretic props
DK405775A (da) * 1974-09-12 1976-03-13 American Cyanamid Co Fremgangsmade til fremstilling af alkanolaminer
GB1473262A (en) * 1974-11-20 1977-05-11 Delalande Sa Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application
JPS5210284A (en) * 1975-07-11 1977-01-26 Tanabe Seiyaku Co Ltd Process for preparing piperazine derivatives
US4166116A (en) * 1977-11-11 1979-08-28 Canadian Patents And Development Limited Pharmaceutical compositions containing piperazinyl acylhydroxamic acid derivatives to treat inflammation or anaphylactic allergy conditions
JPS5732255A (en) * 1980-08-05 1982-02-20 Kowa Co Trimethoxyphenyl derivative

Also Published As

Publication number Publication date
JPH0518830B2 (es) 1993-03-15
FR2522325B1 (fr) 1985-08-09
BE896009A (fr) 1983-08-24
IT8319764A0 (it) 1983-02-25
GB8517121D0 (en) 1985-08-14
GB8517122D0 (en) 1985-08-14
LU84658A1 (fr) 1984-11-08
GB2163153A (en) 1986-02-19
GB2163151B (en) 1986-07-23
SE460788B (sv) 1989-11-20
AU1188983A (en) 1983-09-01
GR77936B (es) 1984-09-25
GB2163152B (en) 1986-07-23
ES8500254A1 (es) 1984-10-01
GB2116967B (en) 1986-07-16
JPS58159484A (ja) 1983-09-21
GB2116967A (en) 1983-10-05
FR2522325A1 (fr) 1983-09-02
ZA831134B (en) 1983-11-30
CH657615A5 (fr) 1986-09-15
DE3306302A1 (de) 1983-09-08
GB8517123D0 (en) 1985-08-14
GB2163152A (en) 1986-02-19
GB2163153B (en) 1986-07-16
SE8300987D0 (sv) 1983-02-23
SE8300987L (sv) 1983-08-27
CA1246076A (en) 1988-12-06
GB8304846D0 (en) 1983-03-23
ES529265A0 (es) 1984-10-01
ES8403881A1 (es) 1984-04-16
US4639452A (en) 1987-01-27
DE3306302C2 (es) 1992-04-02
IT1193684B (it) 1988-07-21
NL8300720A (nl) 1983-09-16
GB2163151A (en) 1986-02-19

Similar Documents

Publication Publication Date Title
ES520089A0 (es) Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina.
ES527986A0 (es) Procedimiento para la produccion de derivados de 1-azolil-2-aril-3-fluoro-alcan-2-ol.
ES517167A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles sustituidos.
ES520180A0 (es) Procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2.
ES504791A0 (es) Procedimiento para la preparacion de derivados de caprolactama.
ES529774A0 (es) Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
ES518518A0 (es) Procedimiento para la fabricacion de nuevos derivados aminoalcoxi aromaticos.
ES527985A0 (es) Procedimiento para la produccion de derivados de 1-fluoro-1-ariloxi-3-azolilmetil-2-alcanol.
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
ES546506A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol.
ES519529A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
ES518272A0 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES520706A0 (es) Procedimiento para la preparacion de sulfonilureas.
ES517153A0 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES518858A0 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
ES521979A0 (es) Procedimiento para la preparacion de disulfuros.
ES521331A0 (es) Procedimiento para la preparacion de n-pteridinilureas.
ES520201A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
ES519085A0 (es) Procedimiento para la preparacion de compuestos de benzotiazol.
ES522859A0 (es) Procedimiento para la obtencion de derivados de trifluormetilfenoxi-fenilo.
ES524129A0 (es) Procedimiento para la fabricacion de nuevos derivados aminoalquil naftalenicos.
ES520986A0 (es) Procedimiento para la preparacion de derivados de 2-piridona.